Literature DB >> 33824867

Periprocedural Peritonitis Prophylaxis: A Summary of the Microbiology and the Role of Systemic Antimicrobials.

Leon Hsueh1,2, Susie L Hu1,3, Ankur D Shah1,3,4.   

Abstract

BACKGROUND: Peritonitis is a leading complication of peritoneal dialysis (PD). One strategy that the International Society for Peritoneal Dialysis (ISPD) has used to help mitigate the morbidity and mortality associated with peritonitis is through prevention, including antibiotic prophylaxis utilization in high-risk situations. The aim of this study is to summarize our current understanding of postprocedural peritonitis and discuss the existing data behind periprocedural antibiotic prophylaxis, focusing primarily on PD catheter insertion, dental procedures, colonoscopies, upper endoscopies with gastrostomy, and gynecologic procedures.
SUMMARY: The ISPD currently recommends intravenous antibiotics prior to PD catheter insertion, colonoscopies, and invasive gynecologic procedures, though prophylaxis has only demonstrated benefit in a prospective, randomized control setting for PD catheter insertion. However, multiple retrospective studies exist that support the use of antibiotic prophylaxis for the other 2 procedures. No specific antibiotic regimen has been established as most optimal to prevent peritonitis for any of the 3 procedures. Antibiotic coverage should include the Enterobacteriaceae family, as well as Gram-positive organisms commonly found on the skin flora for PD catheter insertion, anaerobes for colonoscopies, and common organisms from the urogenital flora in gynecologic procedures. Additionally, the ISPD currently recommends oral amoxicillin prior to dental procedures. There is currently no ISPD recommendation to provide antibiotic prophylaxis prior to an upper endoscopy with or without gastrostomy, though this is a potential area for research. KEY MESSAGES: PD patients are at high risk for developing peritonitis after typical procedures. Antibiotic prophylaxis is a potential strategy that the ISPD utilizes to prevent these infections. However, further research needs to be done to determine the optimal antibiotic regimen.
Copyright © 2021 by S. Karger AG, Basel.

Entities:  

Keywords:  Antibiotics; Periprocedure; Peritoneal dialysis

Year:  2021        PMID: 33824867      PMCID: PMC8010226          DOI: 10.1159/000513773

Source DB:  PubMed          Journal:  Kidney Dis (Basel)        ISSN: 2296-9357


  55 in total

1.  Colonoscopy in automated peritoneal dialysis patients: value of prophylactic antibiotics: a prospective study on a single antibiotic.

Authors:  Abdullah K Al-Hwiesh; Ibrahiem S Abdul-Rahman; Mohammad A Hussameldeen; Nadia Al-Audah; Abdalla Abdelrahman; Hala M Moaigel; Tamer El-Salamony; Abdul-Salam Noor; Aisha Al-Osail; Dalal Al-Sayel; Nourah Al-Dossari
Journal:  Int J Artif Organs       Date:  2017-07-05       Impact factor: 1.595

Review 2.  ISPD Catheter-Related Infection Recommendations: 2017 Update.

Authors:  Cheuk-Chun Szeto; Philip Kam-Tao Li; David W Johnson; Judith Bernardini; Jie Dong; Ana E Figueiredo; Yasuhiko Ito; Rumeyza Kazancioglu; Thyago Moraes; Sadie Van Esch; Edwina A Brown
Journal:  Perit Dial Int       Date:  2017 Mar-Apr       Impact factor: 1.756

3.  Colon Cancer Screening among Patients Receiving Dialysis in the United States: Are We Choosing Wisely?

Authors:  Christopher A Carlos; Charles E McCulloch; Chi-Yuan Hsu; Barbara Grimes; Meda E Pavkov; Nilka R Burrows; Vahakn B Shahinian; Rajiv Saran; Neil R Powe; Kirsten L Johansen
Journal:  J Am Soc Nephrol       Date:  2017-03-23       Impact factor: 10.121

4.  Regional variation in the treatment and prevention of peritoneal dialysis-related infections in the Peritoneal Dialysis Outcomes and Practice Patterns Study.

Authors:  Neil Boudville; David W Johnson; Junhui Zhao; Brian A Bieber; Ronald L Pisoni; Beth Piraino; Judith Bernardini; Sharon J Nessim; Yasuhiko Ito; Graham Woodrow; Fiona Brown; John Collins; Talerngsak Kanjanabuch; Cheuk-Chun Szeto; Jeffrey Perl
Journal:  Nephrol Dial Transplant       Date:  2019-12-01       Impact factor: 5.992

5.  One-dose cefuroxime i.v. and i.p. reduces microbial growth in PD patients after catheter insertion.

Authors:  A M Wikdahl; U Engman; B G Stegmayr; J G Sörenssen
Journal:  Nephrol Dial Transplant       Date:  1997-01       Impact factor: 5.992

6.  Streptococcal PD peritonitis--a 10-year review of one centre's experience.

Authors:  Ashutosh Shukla; Zita Abreu; Joanne M Bargman
Journal:  Nephrol Dial Transplant       Date:  2006-09-27       Impact factor: 5.992

7.  Posthysteroscopy fungal peritonitis in a patient on continuous ambulatory peritoneal dialysis.

Authors:  P K Li; C B Leung; A K Leung; W K Luk; K N Lai
Journal:  Am J Kidney Dis       Date:  1993-04       Impact factor: 8.860

Review 8.  Ceftazidime. An update of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  C P Rains; H M Bryson; D H Peters
Journal:  Drugs       Date:  1995-04       Impact factor: 9.546

9.  Chronic kidney disease and use of dental services in a United States public healthcare system: a retrospective cohort study.

Authors:  Vanessa Grubbs; Laura C Plantinga; Delphine S Tuot; Neil R Powe
Journal:  BMC Nephrol       Date:  2012-04-02       Impact factor: 2.388

10.  The impact of peritoneal dialysis-related peritonitis on mortality in peritoneal dialysis patients.

Authors:  Hongjian Ye; Qian Zhou; Li Fan; Qunying Guo; Haiping Mao; Fengxian Huang; Xueqing Yu; Xiao Yang
Journal:  BMC Nephrol       Date:  2017-06-05       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.